Kominek Courtney
is a Clinical Pharmacy Specialist-Pain Management at the Harry S. Truman Memorial Veterans' Hospital in Columbia, Missouri.
Fed Pract. 2021 Jan;38(1):20-27. doi: 10.12788/fp.0079.
The US Department of Health and Human Services' 5-point strategy to combat the opioid overdose public health crisis includes improved pain management. There is a shortage of adequately trained health care providers in pain management. Advanced practice pharmacists may be able to help fill that void. The objective of this project was to identify the impact of an advanced practice pharmacist with controlled substance prescriptive authority on morphine milligram equivalent dose (MME) and compliance with opioid risk mitigation.
In March 2020, a single-site retrospective chart review was conducted of patients who were prescribed controlled substances from July 1, 2018 to January 31, 2020. Patients received care through the outpatient Pharmacy Pain Clinic in-person or via telephone who were enrolled at the Harry S. Truman Memorial Veterans' Hospital in Columbia, Missouri, or associated outlying outpatient clinics. Patients were included if they were referred to the Pharmacy Pain Clinic and prescribed a Schedule II or III opioid medication. A 2-sided test was conducted to compare MME, and a Fisher exact test was used to compare adherence to opioid risk mitigation.
Patients seen in Pharmacy Pain Clinic had a statistically significant reduction in MME from consult (93 MME) to discharge (31 MME) ( < .01). There was also a statistically significant ( < .01) improvement in use of opioid risk mitigation strategies, including urine drug screen, informed consent, naloxone, prescription drug monitoring program checks, and stratification tool for opioid risk mitigation dashboard reviews.
An advanced practice pharmacist with controlled substance prescriptive authority improved patient care with demonstrated statistically significant differences in MME and adherence with opioid risk mitigation from consult to discharge. Health care teams should look to add advanced practice pharmacists to their team as medication experts to deliver comprehensive medication management, which can include controlled substance prescribing and management.
美国卫生与公众服务部应对阿片类药物过量公共卫生危机的五点战略包括改善疼痛管理。疼痛管理方面缺乏训练有素的医疗保健提供者。高级执业药师或许能够填补这一空白。本项目的目的是确定具有受控物质处方权的高级执业药师对吗啡毫克当量剂量(MME)以及阿片类药物风险缓解依从性的影响。
2020年3月,对2018年7月1日至2020年1月31日期间开具受控物质处方的患者进行了单中心回顾性病历审查。患者通过密苏里州哥伦比亚市哈里·S·杜鲁门纪念退伍军人医院或相关外围门诊诊所的门诊药房疼痛诊所亲自就诊或通过电话接受治疗。如果患者被转诊至药房疼痛诊所并开具了II类或III类阿片类药物,则纳入研究。进行双侧检验以比较MME,并使用Fisher精确检验比较阿片类药物风险缓解的依从性。
在药房疼痛诊所就诊的患者,从会诊时的MME(93 MME)到出院时(31 MME)有统计学显著降低(P<0.01)。阿片类药物风险缓解策略的使用也有统计学显著改善(P<0.01),包括尿液药物筛查、知情同意、纳洛酮、处方药监测计划检查以及阿片类药物风险缓解仪表盘审查的分层工具。
具有受控物质处方权的高级执业药师改善了患者护理,从会诊到出院,在MME以及阿片类药物风险缓解依从性方面显示出统计学显著差异。医疗团队应考虑在其团队中增加高级执业药师作为药物专家,以提供全面的药物管理,这可能包括受控物质的处方和管理。